These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives. Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Murakami M; Oketani K; Inoue T J Med Chem; 1994 Sep; 37(19):3062-70. PubMed ID: 7932529 [TBL] [Abstract][Full Text] [Related]
11. Saiboku-To, a herbal extract mixture, selectively inhibits 5-lipoxygenase activity in leukotriene synthesis in rat basophilic leukemia-1 cells. Kobayashi I; Hamasaki Y; Sato R; Zaitu M; Muro E; Yamamoto S; Ichimaru T; Miyazaki S J Ethnopharmacol; 1995 Aug; 48(1):33-41. PubMed ID: 8569245 [TBL] [Abstract][Full Text] [Related]
12. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors. Spaethe SM; Snyder DW; Pechous PA; Clarke T; VanAlstyne EL Biochem Pharmacol; 1992 Jan; 43(2):377-82. PubMed ID: 1310855 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase. Rubin P; Dubé L; Braeckman R; Swanson L; Hansen R; Albert D; Carter G Agents Actions Suppl; 1991; 35():103-16. PubMed ID: 1781415 [TBL] [Abstract][Full Text] [Related]
14. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4). Surette ME; Krump E; Picard S; Borgeat P Mol Pharmacol; 1999 Nov; 56(5):1055-62. PubMed ID: 10531413 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase. Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Harada K; Miyamoto K; Yamatsu I J Med Chem; 1996 Aug; 39(16):3148-57. PubMed ID: 8759636 [TBL] [Abstract][Full Text] [Related]
16. 4-Methoxy-2-methyltetrahydropyrans: chiral leukotriene biosynthesis inhibitors, related to ICI D2138, which display enantioselectivity. Crawley GC; Briggs MT; Dowell RI; Edwards PN; Hamilton PM; Kingston JF; Oldham K; Waterson D; Whalley DP J Med Chem; 1993 Jan; 36(2):295-6. PubMed ID: 8380872 [No Abstract] [Full Text] [Related]
17. Platelet-activating factor and leukotriene biosynthesis in whole blood. A model for the study of transcellular arachidonate metabolism. Fradin A; Zirrolli JA; Maclouf J; Vausbinder L; Henson PM; Murphy RC J Immunol; 1989 Dec; 143(11):3680-5. PubMed ID: 2555415 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition. Stanke-Labesque F; Devillier P; Bedouch P; Cracowski JL; Chavanon O; Bessard G Cardiovasc Res; 2000 Aug; 47(2):376-83. PubMed ID: 10946074 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of quinolinones as methionyl-tRNA synthetase inhibitors. Farhanullah ; Kim SY; Yoon EJ; Choi EC; Kim S; Kang T; Samrin F; Puri S; Lee J Bioorg Med Chem; 2006 Nov; 14(21):7154-9. PubMed ID: 16854585 [TBL] [Abstract][Full Text] [Related]
20. Medicinal plants from nepal: evaluation as inhibitors of leukotriene biosynthesis. Kumar S; Ziereis K; Wiegrebe W; Müller K J Ethnopharmacol; 2000 Jun; 70(3):191-5. PubMed ID: 10837982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]